News
-
-
PRESS RELEASE
Amoéba accelerates the development of Axpera: Very convincing results observed by winegrowers; An approval schedule in line with the market launch in 2026.
Amoéba to present positive results of wine-growing trials with its innovative biological solution 'AXPERA' to agricultural press, amidst changing plant health regulations in France and Europe -
-
-
-
PRESS RELEASE
Amoéba announces the success of its capital increase of 14 M EUR to support its industrial and commercial deployment
Amoéba (FR0011051598 - ALMIB) successfully raises €14 million through a capital increase to support industrial and commercial expansion. Investors incl. Nice & Green show confidence. New shares to be admitted on Euronext Growth market of Euronext Paris -
-
PRESS RELEASE
Amoéba launches a capital increase open to all to support its industrial and commercial deployment
Amoéba, a greentech company, announces a capital increase of up to €14 million to support industrial and commercial growth in biocontrol and cosmetics. Key partners and subscription commitments outlined -
-
PRESS RELEASE
Amoéba signs an agreement with Metron Technology, a subsidiary of Oriental Beauty Valley (OBV), a key player in the cosmetics industry in China
Amoéba signs agreement with Metron Technology, subsidiary of Oriental Beauty Valley, for cosmetic ingredient in China. Accelerating entry into second largest cosmetics market